Selected article for: "cell line and dose dependent reduction"

Author: Marcotullio, Maria Carla; Pelosi, Azzurra; Curini, Massimo
Title: Hinokinin, an Emerging Bioactive Lignan
  • Document date: 2014_9_17
  • ID: 04kh4yzy_10
    Snippet: Hinokinin was also examined as antitumor promoter agent in a human cytomegalovirus (HCMV) immediate early (IE) antigen expression in human lung adenocarcinoma (A-549) cells [70] . After establishing the ID50 (dose causing 50% inhibition) in A-549 cell line (40.72 μg/mL), the authors found that 1 was able to reduce the IE antigen expression in HCMV-infected lung cancer cells in a dose-dependent manner (ID1: 81, ID10: 57% reduction, respectively)......
    Document: Hinokinin was also examined as antitumor promoter agent in a human cytomegalovirus (HCMV) immediate early (IE) antigen expression in human lung adenocarcinoma (A-549) cells [70] . After establishing the ID50 (dose causing 50% inhibition) in A-549 cell line (40.72 μg/mL), the authors found that 1 was able to reduce the IE antigen expression in HCMV-infected lung cancer cells in a dose-dependent manner (ID1: 81, ID10: 57% reduction, respectively). [67] ; e [28] .

    Search related documents:
    Co phrase search for related documents
    • antigen expression and dose dependent manner: 1, 2
    • antigen expression and HCMV human cytomegalovirus: 1
    • antigen expression and human cytomegalovirus: 1
    • antigen expression and lung cancer: 1, 2
    • antigen expression and lung cancer cell: 1
    • cell line and dose dependent manner: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cell line and HCMV human cytomegalovirus: 1, 2, 3
    • cell line and human cytomegalovirus: 1, 2, 3, 4, 5, 6, 7
    • cell line and human lung adenocarcinoma: 1, 2, 3, 4, 5, 6
    • cell line and human lung adenocarcinoma cell: 1, 2, 3, 4, 5, 6
    • cell line and μg mL cell line: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • cell line and lung adenocarcinoma: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • cell line and lung cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cell line and lung cancer cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • dose dependent manner and human cytomegalovirus: 1
    • dose dependent manner and μg mL cell line: 1
    • dose dependent manner and lung adenocarcinoma: 1
    • dose dependent manner and lung cancer: 1, 2, 3, 4
    • dose dependent manner and lung cancer cell: 1, 2, 3